Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

Journal of cellular and molecular medicine - 1 Jul 2015

Circelli Luisa, Ramundo Valeria, Marotta Vincenzo, Sciammarella Concetta, Marciello Francesca, Del Prete Michela, Sabatino Lina, Pasquali Daniela, Izzo Francesco, Scala Stefania, Colao Annamaria, Faggiano Antongiulio, Colantuoni Vittorio

Abstract excerpt

CDKN1B encodes the cyclin-dependent kinase inhibitor p27/Kip1. CDKN1B mutations and polymorphisms are involved in tumorigenesis; specifically, the V109G single nucleotide polymorphism has been linked to different tumours with controversial results. Multiple endocrine neoplasia type 1 (MEN1) is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Cyclin-Dependent Kinase Inhibitor p27

Share to Gene Frequency

Share to Multiple Endocrine Neoplasia Type 1

Share to Prognosis

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 25824098
DOI: 10.1111/jcmm.12552
PMCID: PMC4511370

Genes

MEN1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25824098-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.PMID 25824098Read ↗

Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.Semantic proximity Read ↗

Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.Semantic proximity Read ↗

A novel mutation E179K of the MEN1 gene predisposes for multiple endocrine neoplasia-type 1 (MEN1).Semantic proximity Read ↗

MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients.Semantic proximity Read ↗

Heterogeneity of the Clinical Presentation of the MEN1 LRG_509 c.781C>T (p.Leu261Phe) Variant Within a Three-Generation Family.Semantic proximity Read ↗

Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.Semantic proximity Read ↗

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.Semantic proximity Read ↗

Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies.Semantic proximity Read ↗

A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.Semantic proximity Read ↗

Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.Semantic proximity Read ↗

VIPoma with multiple endocrine neoplasia type 1 identified as an atypical gene mutation.Semantic proximity Read ↗

Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.